FNCHFinch Therapeutics Group, Inc.

About Finch Therapeutics Group, Inc. (FNCH)

Finch Therapeutics Group, Inc. (FNCH) is a Biotechnology company headquartered in Boston, MA, United States whose shares trade over-the-counter on the Pink tier.

Finch Therapeutics is a microbiome technology company with a portfolio of intellectual property and microbiome assets. Finch's objectives are to realize the value of its intellectual property estate through licensing its technology to collaboration partners and enforcing its patent rights against infringing parties through intellectual property litigation and, in certain cases, to generate additional data on selected product candidates through academic collaborations.

Products and services

Finch currently has no marketed products or services and is instead focused on realizing the value of its intellectual property estate through licensing its technology to collaboration partners and enforcing its patent rights against infringing parties through intellectual property litigation and, in certain cases, generating additional data on selected product candidates through academic collaborations.

FNCH key facts

Ticker symbol

FNCH

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Boston, MA, United States

Country of incorporation

US

Year of incorporation

2017

Employees

1

Estimated market cap

$20.07M (as of Apr 10, 2025)

Shares outstanding

1,605,763

Reporting standard

Alternative Reporting Standard

Audit status

Audited

Fiscal year end

12/31

Finch Therapeutics Group, Inc. leadership

• Matthew P. Blischak — CEO
• Adriana Polcaro — Consultant

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with F